FDA grants approval for first Alzheimer's drug slowing disease progression 07-Jul-2023 By Liza Laws The first and only approved anti-amyloid Alzheimer's Disease (AD) treatment shown to reduce the rate of disease progression and slow cognitive impairment has been granted approval by the FDA.